Literature DB >> 36087079

Fifty years of bone tumors.

Meredith K Bartelstein1, Patrick J Boland1.   

Abstract

There have been enormous advances in the treatment of bone tumors over the past half-century. The most notable of these has been the transition from amputation as the standard of care to limb salvage surgery. This transition is the result of advances in imaging techniques, accurate diagnosis, systemic therapies (including chemotherapy), and prosthetic design for the reconstruction of musculoskeletal defects. Advances have also been made in the management of benign and metastatic bone tumors.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  bone; limb salvage; metastasis; sarcoma

Mesh:

Year:  2022        PMID: 36087079      PMCID: PMC9524618          DOI: 10.1002/jso.27027

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   2.885


  71 in total

1.  Cyclophosphamide in children with cancer.

Authors:  D PINKEL
Journal:  Cancer       Date:  1962 Jan-Feb       Impact factor: 6.860

2.  Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies.

Authors:  W W Sutow; E A Gehan; P G Dyment; T Vietti; T Miale
Journal:  Cancer Treat Rep       Date:  1978-02

Review 3.  Radiofrequency ablation for spinal osteoid osteoma: A systematic review of safety and treatment outcomes.

Authors:  Navraj S Sagoo; Ali S Haider; Andrew L Chen; Christopher Vannabouathong; Kylan Larsen; Ruhi Sharma; Paolo Palmisciano; Othman Bin Alamer; Matthew Igbinigie; Daniel B Wells; Salah G Aoun; Peter G Passias; Shaleen Vira
Journal:  Surg Oncol       Date:  2022-03-25       Impact factor: 3.279

4.  Rotationplasty as a reconstructive operation after tumor resection.

Authors:  K D Merkel; M Gebhardt; D S Springfield
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

5.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

6.  Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience.

Authors:  D B Glasser; J M Lane; A G Huvos; R C Marcove; G Rosen
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

7.  Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures.

Authors:  H Mirels
Journal:  Clin Orthop Relat Res       Date:  1989-12       Impact factor: 4.176

8.  High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

Authors:  Jeremy Whelan; Marie-Cecile Le Deley; Uta Dirksen; Gwénaël Le Teuff; Bernadette Brennan; Nathalie Gaspar; Douglas S Hawkins; Susanne Amler; Sebastian Bauer; Stefan Bielack; Jean-Yves Blay; Stefan Burdach; Marie-Pierre Castex; Dagmar Dilloo; Angelika Eggert; Hans Gelderblom; Jean-Claude Gentet; Wolfgang Hartmann; Wolf-Achim Hassenpflug; Lars Hjorth; Marta Jimenez; Thomas Klingebiel; Udo Kontny; Jarmila Kruseova; Ruth Ladenstein; Valerie Laurence; Cyril Lervat; Perrine Marec-Berard; Sandrine Marreaud; Jean Michon; Bruce Morland; Michael Paulussen; Andreas Ranft; Peter Reichardt; Hendrik van den Berg; Keith Wheatley; Ian Judson; Ian Lewis; Alan Craft; Heribert Juergens; Odile Oberlin
Journal:  J Clin Oncol       Date:  2018-09-06       Impact factor: 44.544

9.  Osteosarcoma: evolution of treatment paradigms.

Authors:  Norman Jaffe; Ajay Puri; Hans Gelderblom
Journal:  Sarcoma       Date:  2013-05-27

10.  External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.

Authors:  Ashley B Anderson; Rikard Wedin; Nicola Fabbri; Patrick Boland; John Healey; Jonathan A Forsberg
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.